Table 2 Summary of patient characteristics
Characteristics | All patients N = 26 |
|---|---|
Age in years | |
Mean ± SD, (Range) | 59.3 ± 10.4, (28, 78) |
Female sex | 9 (35%) |
Caucasian | 20 (77%) |
Length of Hospital Stay in days | |
Mean ± SD, (Range) | 11.5 ± 17.8, (2, 77) |
Length of ICU Stay in days | |
Mean ± SD, (Range) | 4.0 ± 14.4, (0, 63) |
ASA | |
2 | 2 (8%) |
3 | 24 (92%) |
Lee Cardiac Risk Index | |
2 | 25 (96%) |
3 | 1 (4%) |
ACC/AHA Risk Score | |
≤ 1 | 23 (89%) |
> 1 | 3 (11%) |
Chemotherapy | |
No | 13 (50%) |
Yes | 13 (50%) |
Radiation | |
No | 15 (58%) |
Yes | 11 (42%) |
Obesity* | |
No | 16 (61%) |
Yes | 10 (39%) |
Current/Former Smoker | |
No | 9 (35%) |
Yes | 17 (65%) |
Coronary Artery Disease | |
No | 26 (100%) |
Yes | 0 (0%) |
Hypertension | |
No | 12 (46%) |
Yes | 14 (54%) |
Diabetes mellitus | |
No | 23 (88%) |
Yes | 3 (12%) |
Dyslipidemia | |
No | 17 (65%) |
Yes | 9 (35%) |
Statin Therapy | |
No | 20 (77%) |
Yes | 6 (23%) |
Beta-blocker Therapy | |
No | 20 (77%) |
Yes | 6 (23%) |
ACE-Inhibitor Therapy | |
No | 23 (88%) |
Yes | 3 (12%) |
AT2-Inhibitor Therapy | |
No | 25 (96%) |
Yes | 1 (4%) |